Adult Precursor T-Lymphoblastic Leukemia/Lymphoma with Myeloid-Associated Antigen Expression Is Associated with a Lower Complete Remission Rate following Induction Chemotherapy

Murtadha Al Khabori, Samira Samiee, Sharon Fung, Wei Xu, Joseph Brandwein, Bruce Patterson, William Brien, Hong Chang

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Prognostic studies of T-cell lymphoblastic leukemia/lymphoma (T-ALL) have been performed in small patient cohorts with conflicting results. We systematically reviewed 67 adult T-ALL patients diagnosed and treated at our institute to identify clinical and pathologic prognostic factors. The median initial WBC was 21.3 × 109/l. Blasts expressed at least one myeloid-associated antigen in 33%. Karyotypes were abnormal in 32% of the cases. Fifty-six of 64 patients (88%) achieved complete remission (CR). In univariate analysis, age, gender, initial WBC, CD10, CD34 and abnormal karyotype did not predict CR. Patients expressing at least one myeloid-associated antigen had a CR of 74% compared to 94% (p = 0.04) for those not expressing myeloid antigens. None of the above factors affected relapse-free or overall survival in this cohort. Our study indicates that expression of myeloid-associated antigens is associated with a lower CR rate in adult T-ALL and may be considered in risk stratification for induction chemotherapy.

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalActa Haematologica
Volume120
Issue number1
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Induction Chemotherapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Antigens
Abnormal Karyotype
Adult T Cell Leukemia Lymphoma
T-Cell Leukemia
Recurrence
Survival

Keywords

  • Adult T-lymphoblastic leukemia/lymphoma
  • Cytogenetics
  • Immunophenotype
  • Lymphoblastic leukemia/lymphoma, prognosis
  • Myeloid-associated antigens

ASJC Scopus subject areas

  • Hematology

Cite this

Adult Precursor T-Lymphoblastic Leukemia/Lymphoma with Myeloid-Associated Antigen Expression Is Associated with a Lower Complete Remission Rate following Induction Chemotherapy. / Al Khabori, Murtadha; Samiee, Samira; Fung, Sharon; Xu, Wei; Brandwein, Joseph; Patterson, Bruce; Brien, William; Chang, Hong.

In: Acta Haematologica, Vol. 120, No. 1, 10.2008, p. 5-10.

Research output: Contribution to journalArticle

Al Khabori, Murtadha ; Samiee, Samira ; Fung, Sharon ; Xu, Wei ; Brandwein, Joseph ; Patterson, Bruce ; Brien, William ; Chang, Hong. / Adult Precursor T-Lymphoblastic Leukemia/Lymphoma with Myeloid-Associated Antigen Expression Is Associated with a Lower Complete Remission Rate following Induction Chemotherapy. In: Acta Haematologica. 2008 ; Vol. 120, No. 1. pp. 5-10.
@article{f76f23e8686142a08dc6a40e2ed3e792,
title = "Adult Precursor T-Lymphoblastic Leukemia/Lymphoma with Myeloid-Associated Antigen Expression Is Associated with a Lower Complete Remission Rate following Induction Chemotherapy",
abstract = "Prognostic studies of T-cell lymphoblastic leukemia/lymphoma (T-ALL) have been performed in small patient cohorts with conflicting results. We systematically reviewed 67 adult T-ALL patients diagnosed and treated at our institute to identify clinical and pathologic prognostic factors. The median initial WBC was 21.3 × 109/l. Blasts expressed at least one myeloid-associated antigen in 33{\%}. Karyotypes were abnormal in 32{\%} of the cases. Fifty-six of 64 patients (88{\%}) achieved complete remission (CR). In univariate analysis, age, gender, initial WBC, CD10, CD34 and abnormal karyotype did not predict CR. Patients expressing at least one myeloid-associated antigen had a CR of 74{\%} compared to 94{\%} (p = 0.04) for those not expressing myeloid antigens. None of the above factors affected relapse-free or overall survival in this cohort. Our study indicates that expression of myeloid-associated antigens is associated with a lower CR rate in adult T-ALL and may be considered in risk stratification for induction chemotherapy.",
keywords = "Adult T-lymphoblastic leukemia/lymphoma, Cytogenetics, Immunophenotype, Lymphoblastic leukemia/lymphoma, prognosis, Myeloid-associated antigens",
author = "{Al Khabori}, Murtadha and Samira Samiee and Sharon Fung and Wei Xu and Joseph Brandwein and Bruce Patterson and William Brien and Hong Chang",
year = "2008",
month = "10",
doi = "10.1159/000146081",
language = "English",
volume = "120",
pages = "5--10",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Adult Precursor T-Lymphoblastic Leukemia/Lymphoma with Myeloid-Associated Antigen Expression Is Associated with a Lower Complete Remission Rate following Induction Chemotherapy

AU - Al Khabori, Murtadha

AU - Samiee, Samira

AU - Fung, Sharon

AU - Xu, Wei

AU - Brandwein, Joseph

AU - Patterson, Bruce

AU - Brien, William

AU - Chang, Hong

PY - 2008/10

Y1 - 2008/10

N2 - Prognostic studies of T-cell lymphoblastic leukemia/lymphoma (T-ALL) have been performed in small patient cohorts with conflicting results. We systematically reviewed 67 adult T-ALL patients diagnosed and treated at our institute to identify clinical and pathologic prognostic factors. The median initial WBC was 21.3 × 109/l. Blasts expressed at least one myeloid-associated antigen in 33%. Karyotypes were abnormal in 32% of the cases. Fifty-six of 64 patients (88%) achieved complete remission (CR). In univariate analysis, age, gender, initial WBC, CD10, CD34 and abnormal karyotype did not predict CR. Patients expressing at least one myeloid-associated antigen had a CR of 74% compared to 94% (p = 0.04) for those not expressing myeloid antigens. None of the above factors affected relapse-free or overall survival in this cohort. Our study indicates that expression of myeloid-associated antigens is associated with a lower CR rate in adult T-ALL and may be considered in risk stratification for induction chemotherapy.

AB - Prognostic studies of T-cell lymphoblastic leukemia/lymphoma (T-ALL) have been performed in small patient cohorts with conflicting results. We systematically reviewed 67 adult T-ALL patients diagnosed and treated at our institute to identify clinical and pathologic prognostic factors. The median initial WBC was 21.3 × 109/l. Blasts expressed at least one myeloid-associated antigen in 33%. Karyotypes were abnormal in 32% of the cases. Fifty-six of 64 patients (88%) achieved complete remission (CR). In univariate analysis, age, gender, initial WBC, CD10, CD34 and abnormal karyotype did not predict CR. Patients expressing at least one myeloid-associated antigen had a CR of 74% compared to 94% (p = 0.04) for those not expressing myeloid antigens. None of the above factors affected relapse-free or overall survival in this cohort. Our study indicates that expression of myeloid-associated antigens is associated with a lower CR rate in adult T-ALL and may be considered in risk stratification for induction chemotherapy.

KW - Adult T-lymphoblastic leukemia/lymphoma

KW - Cytogenetics

KW - Immunophenotype

KW - Lymphoblastic leukemia/lymphoma, prognosis

KW - Myeloid-associated antigens

UR - http://www.scopus.com/inward/record.url?scp=54249162407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249162407&partnerID=8YFLogxK

U2 - 10.1159/000146081

DO - 10.1159/000146081

M3 - Article

VL - 120

SP - 5

EP - 10

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 1

ER -